Jeffrey Peters All publications ( 27 ) Girroir EE. Hollingshead HE. He P. Zhu B. Perdew GH. Peters JM. Quantitative expression patterns of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) protein in mice. 2008 Jul 4. Biochem Biophys Res Commun. 371(3):456-61. Girroir EE. Hollingshead HE. Billin AN. Willson TM. Robertson GP. Sharma AK. Amin S. Gonzalez FJ. Peters JM. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines. 2008 Jan 14. Toxicology. 243(1-2):236-43. Shan W. Nicol CJ. Ito S. Bility MT. Kennett MJ. Ward JM. Gonzalez FJ. Peters JM. Peroxisome proliferator-activated receptor-beta/delta protects against chemically induced liver toxicity in mice. 2008 Jan. Hepatology. 47(1):225-35. Borland MG. Foreman JE. Girroir EE. Zolfaghari R. Sharma AK. Amin SM. Gonzalez FJ. Ross AC. Peters JM. Ligand Activation of Peroxisome Proliferator-Activated Receptor-{beta}/{delta} (PPAR{beta}/{delta}) Inhibits Cell Proliferation in Human HaCaT Keratinocytes. 2008 Aug 13. Mol Pharmacol. . Peters JM. Hollingshead HE. Gonzalez FJ. Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease. 2008 Aug. Clin Sci (Lond). 115(4):107-27. Hollingshead HE. Borland MG. Billin AN. Willson TM. Gonzalez FJ. Peters JM. Ligand activation of peroxisome proliferator-activated receptor-{beta}/{delta} (PPAR{beta}/{delta}) and inhibition of cyclooygenase-2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms. 2007 Sep 24. Carcinogenesis. . Hollingshead HE. Morimura K. Adachi M. Kennett MJ. Billin AN. Willson TM. Gonzalez FJ. Peters JM. PPARbeta/delta protects against experimental colitis through a ligand-independent mechanism. 2007 Nov. Dig Dis Sci. 52(11):2912-9. Burdick AD. Bility MT. Girroir EE. Billin AN. Willson TM. Gonzalez FJ. Peters JM. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes. 2007 Jun. Cell Signal. 19(6):1163-71. National Cancer Institute Hollingshead HE. Killins RL. Borland MG. Girroir EE. Billin AN. Willson TM. Sharma AK. Amin S. Gonzalez FJ. Peters JM. Peroxisome proliferator-activated receptor-{beta}/{delta} (PPAR{beta}/{delta}) ligands do not potentiate growth of human cancer cell lines. 2007 Aug 11. Carcinogenesis. . Coleman JD. Prabhu KS. Thompson JT. Reddy PS. Peters JM. Peterson BR. Reddy CC. Vanden Heuvel JP. The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta). 2007 Apr 15. Free Radic Biol Med. 42(8):1155-64. National Institute of Allergy and Infectious Diseases National Cancer Institute National Institute of General Medical Sciences Kim DJ. Prabhu KS. Gonzalez FJ. Peters JM. Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-{beta}/{delta} (PPAR{beta}/{delta}). 2006 May. Carcinogenesis. 27(5):1105-1112. Kim DJ. Bility MT. Billin AN. Willson TM. Gonzalez FJ. Peters JM. PPARbeta/delta selectively induces differentiation and inhibits cell proliferation. 2006 Jan. Cell Death Differ. 13(1):53-60. National Cancer Institute Burdick AD. Kim DJ. Peraza MA. Gonzalez FJ. Peters JM. The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation. 2006 Jan. Cell Signal. 18(1):9-20. National Cancer Institute Patel RD. Kim DJ. Peters JM. Perdew GH. The aryl hydrocarbon receptor directly regulates expression of the potent mitogen epiregulin. 2006 Jan. Toxicol Sci. 89(1):75-82. National Institute of Environmental Health Sciences Marin HE. Peraza MA. Billin AN. Willson TM. Ward JM. Kennett MJ. Gonzalez FJ. Peters JM. Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis. 2006 Apr 15. Cancer Res. 66(8):4394-401. National Cancer Institute Peraza MA. Burdick AD. Marin HE. Gonzalez FJ. Peters JM. The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). 2006 Apr. Toxicol Sci. 90(2):269-95. National Cancer Institute Murray IA. Reen RK. Leathery N. Ramadoss P. Bonati L. Gonzalez FJ. Peters JM. Perdew GH. Evidence that ligand binding is a key determinant of Ah receptor-mediated transcriptional activity. 2005 Oct 1. Arch Biochem Biophys. 442(1):59-71. National Institute of Environmental Health Sciences Peters JM. Cheung C. Gonzalez FJ. Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand? 2005 Oct. J Mol Med. 83(10):774-85. Kim DJ. Murray IA. Burns AM. Gonzalez FJ. Perdew GH. Peters JM. Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity. 2005 Mar 11. J Biol Chem. 280(10):9519-27. National Cancer Institute National Institute of Environmental Health Sciences Hays T. Rusyn I. Burns AM. Kennett MJ. Ward JM. Gonzalez FJ. Peters JM. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis. 2005 Jan. Carcinogenesis. 26(1):219-27. National Cancer Institute Peters JM. Kato S. Gonzalez FJ. The United States-Japan workshop on: The role of nuclear receptors in carcinogenesis. 2004 Oct. Mol Carcinog. 41(2):77-84. Bility MT. Thompson JT. McKee RH. David RM. Butala JH. Vanden Heuvel JP. Peters JM. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters. 2004 Nov. Toxicol Sci. 82(1):170-82. National Cancer Institute Kim DJ. Akiyama TE. Harman FS. Burns AM. Shan W. Ward JM. Kennett MJ. Gonzalez FJ. Peters JM. Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis. 2004 May 28. J Biol Chem. 279(22):23719-27. National Cancer Institute Harman FS. Nicol CJ. Marin HE. Ward JM. Gonzalez FJ. Peters JM. Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis. 2004 May. Nat Med. 10(5):481-3. National Cancer Institute Tien ES. Gray JP. Peters JM. Vanden Heuvel JP. Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes. 2003 Sep 15. Cancer Res. 63(18):5767-80. National Institute of Diabetes and Digestive and Kidney Diseases Peters JM. Aoyama T. Burns AM. Gonzalez FJ. Bezafibrate is a dual ligand for PPARalpha and PPARbeta: studies using null mice. 2003 Jun 10. Biochim Biophys Acta. 1632(1-3):80-9. National Cancer Institute Peters JM. Park Y. Gonzalez FJ. Pariza MW. Influence of conjugated linoleic acid on body composition and target gene expression in peroxisome proliferator-activated receptor alpha-null mice. 2001 Oct 31. Biochim Biophys Acta. 1533(3):233-42.